Lv2
166 积分 2023-10-30 加入
Monoclonal antibodies – A repertoire of therapeutics
24天前
已完结
Monoclonal antibodies – A repertoire of therapeutics
29天前
已完结
Development and characterization of monoclonal antibodies against canine PD-1 and PD-L1
2个月前
已完结
Cosibelimab: First Approval
2个月前
已关闭
The opportunities and challenges in immunotherapy: Insights from the regulation of PD-L1 in cancer cells
2个月前
已完结
Could immune checkpoints PD-1/PD-L1, PD-L2 and CTLA-4 be valuable in the spontaneous canine model of breast cancer?
2个月前
已完结
Atezolizumab Extends Survival for Breast Cancer
2个月前
已完结
Atezolizumab Extends Survival for Breast Cancer
2个月前
已关闭
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer
2个月前
已完结
Immunotherapy Applications (Telomerase and HER2) with Gene Electrotransfer
2个月前
已完结
皖公网安备34019202002308
